Clinical review: immunodepression in the surgical patient and increased susceptibility to infection

Martin K Angele, Eugen Faist, Martin K Angele, Eugen Faist

Abstract

Several studies indicate that organ failure is the leading cause of death in surgical patients. An excessive inflammatory response followed by a dramatic paralysis of cell-mediated immunity following major surgery appears to be responsible for the increased susceptibility to subsequent sepsis. In view of this, most of the scientific and medical research has been directed towards measuring the progression and inter-relationship of mediators following major surgery. Furthermore, the effect of those mediators on cell-mediated immune responses has been studied. This article will focus on the effect of blood loss and surgical injury on cell-mediated immune responses in experimental studies utilizing models of trauma and hemorrhagic shock, which have defined effects on the immunoinflammatory response. Subsequently these findings will be correlated with data generated from surgical patients. The results of these studies may generate new approaches for the treatment of immunodepression following major surgery, thus reducing the susceptibility to infection and increasing the survival rate of the critical ill surgical patient.

Figures

Figure 1
Figure 1
Arbitrary blood cytokine levels during the first 24 hours following trauma and hemorrhagic shock. Levels of tumor necrosis factor α (TNF-α), IL-6, and transforming growth factor β (TGF-β) were determined by specific bioassay. IL-10 was measured by ELISA and corticosterone was measured by radioimmunoassay.
Figure 2
Figure 2
Hypothesis of the cascade of events following major surgery that lead to the development of depressed immune responses and increased susceptibility to sepsis. TGF-β, transforming growth factor β ; TNF-α, tumor necrosis factor α.

References

    1. Carrico CJ, Meakins JL, Marshall JC. Multiple organ failure syndrome. Arch Surg. 1986;121:196–208.
    1. Stahl GL, Bitterman H, Terashita Z, Lefer AM. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock. Eur J Pharmacol. 1988;149:233–240.
    1. Chaudry IH, Ayala A. Immunological Aspects of Hemorrhage Austin: Medical Intelligence Unit, RG Landes Company; 1992.
    1. Stephan RN, Ayala A, Chaudry IH. Monocyte and lymphocyte responses following trauma. In: Schlag G, Redl H, editor. In Pathophysiology of Shock, Sepsis and Organ Failure. Berlin: Springer-Verlag; 1993. pp. 131–144.
    1. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, Nieuwenhuijzen GAP, Sauerwein RW, van der Meer JW, Goris RJA. Cytokine patterns in patients after major surgery, hemorrhagic shock, and severe blunt trauma. Ann Surg. 1993;6:769–776.
    1. Faist E, Baue AE, Dittmer H. Multiple organ failure in poly-trauma patients. J Trauma. 1983;23:775–787.
    1. Haupt W, Riese J, Mehler C, Weber K, Zowe M, Hohenberger W. Monocyte function before and after surgical trauma. Dig Surg. 1998;15:102–104.
    1. Faist E, Storck M, Hultner L, Redl H, Ertel W, Walz A, Schildberg FW. Functional analysis of monocytes activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care. Surgery. 1992;112:562–572.
    1. Hensler T, Ecker H, Eeg K, Eidecke CD, Artels H, Arthlen W, Agner H, Iewert JR, Olzmann B. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun. 1997;65:2283–2291.
    1. Fingerle-Rowson G, Auers J, Kreuzer E, Fraunberger P, Blumenstein M, Ziegler-Heitbrock LH. Expansion of CD14+CD16+ monocytes in critically ill cardiac surgery patients. Inflammation. 1998;22:367–379.
    1. Ayala A, Ertel W, Chaudry IH. Trauma-induced suppression of antigen presentation and expression of major histocompati-bility class II antigen complex in leukocytes. Shock. 1996;5:79–90.
    1. Schinkel C, Sendtner R, Zimmer S, Faist E. Functional analysis of monocyte subsets in surgical sepsis. J Trauma. 1998;44:743–748.
    1. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg. 1993;80:205–209.
    1. MacLean LD, Meakins JL, Taguchi K, Duignan J, Dhillon KS, Gordon J. Host resistance in sepsis and trauma. Ann Surg. 1975;182:207–211.
    1. Christou NV, Tellado JM. The impact of preexisting disease conditions for host defense integrity in traumatized and critically ill patients. In: Faist E, Meakins J, Schildberg FW, editor. In Host Defense Dysfunction in Trauma, Shock and Sepsis. Berlin-Heidelberg: Springer-Verlag; 1993. pp. 73–82.
    1. Levy EM, Alharbi SA, Grindlinger G, Black PH. Changes in mitogen responsiveness lymphocyte subsets after traumatic injury: relation to development of sepsis. Clin Immunol Immunopathol. 1984;32:224–233.
    1. Keane RM, Birmingham W, Shatney CM, Winchurch RA, Munster AM. Prediction of sepsis in the multitraumatic patient by assays of lymphocyte responsiveness. Surg Gynecol Obstet. 1983;156:163–167.
    1. Ayala A, Lehman DL, Herdon CD, Chaudry IH. Mechanism of enhanced susceptibility to sepsis following hemorrhage: interleukin (IL)-10 suppression of T-cell response is mediated by eicosanoid induced IL-4 release. Arch Surg. 1994;129:1172–1178.
    1. Stephan RN, Kupper TS, Geha AS, Baue AE, Chaudry IH. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg. 1987;122:62–68.
    1. Riddle PR, Berenbaum MC. Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet. 1967;i:746–748.
    1. O'Mahony JB, Palder SB, Wood JJ, McIrvine A, Rodrick ML, Demling RH, Mannick JA. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma. 1984;24:869–875.
    1. Daniels JC, Sakai H, Cobb EK, Lewis SR, Larson DL, Ritzmann SE. Evaluation of lymphocyte reactivity studies in patients with thermal burns. J Trauma. 1971;11:595–607.
    1. Sakai H, Daniels JC, Lewis SR, Lynch JB, Watson DL, Ritzmann SE. Reversible alterations of nucleic acid synthesis in lymphocytes after thermal burns. J Reticuloendothelial Soc. 1972;11:19–28.
    1. Abraham E, Chang YH. The effects of hemorrhage on mitogen-induced lymphocyte proliferation. Circ Shock. 1985;15:141–149.
    1. Angele MK, Ayala A, Cioffi WG, Bland KI, Chaudry IH. Testosterone: the culprit for producing splenocyte depression following trauma-hemorrhage. Am J Physiol. 1998;274:C1530–C1536.
    1. Zellweger R, Ayala A, DeMaso CM, Chaudry IH. Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock. 1995;4:149–153.
    1. Lyons A, Goebel A, Mannick JA, Lederer JA. Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. Arch Surg. 1999;134:1317–1323.
    1. van der Poll T, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, Nguyen L, Goldman M, Moldawer LL, Lowry SF. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol. 1995;155:5397–5401.
    1. Feeney C, Bryzman S, Kong L, Brazil H, Deutsch R, Fritz LC. T-lymphocyte subsets in acute illness. Crit Care Med. 1995;23:1680–1685.
    1. O'Mahony JB, Wood JJ, Rodrick ML, Mannick JA. Changes in T lymphocyte subsets following injury. Assessment by flow cytometry and relationship to sepsis. Ann Surg. 1985;202:580–586.
    1. Abraham E, Freitas AA. Hemorrhage in mice induces alterations in immunoglobulin-secreting B-cells. Crit Care Med. 1989;17:1015–1019.
    1. Abraham E, Freitas AA. Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation. J Immunol. 1989;142:899–906.
    1. Fuchs D, Gruber A, Wachter H, Faist E. Activated cell-mediated immunity and immunodeficiency in trauma and sepsis. In: Faist E, Baue AE, Schildberg FW, editor. In The Immune Consequences of Trauma, Shock and Sepsis Mechanisms and Therapeutic Approaches. Lengerich: Pabst Science Publishers; 1996. pp. 235–239.
    1. Fuchs D, Malkovsky M, Reibnegger G, Werner ER, Forni G, Wachter H. Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol Lett. 1989;December 23:103–108.
    1. Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine. 1990;2:170–174.
    1. Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH. Differential alterations in plasma IL-6 and TNF levels following trauma and hemorrhage. Am J Physiol. 1991;260:R167–R171.
    1. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 1989;17:975–978.
    1. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992;215:356–362.
    1. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol. 1996;80:225–235. doi: 10.1006/clin.1996.0118.
    1. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med. 1997;25:1813–1819.
    1. Ertel W, Morrison MH, Ayala A, Perrin MM, Chaudry IH. Anti-TNF monoclonal antibodies prevent haemorrhage-induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression. Immunology. 1991;74:290–297.
    1. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med. 1990;172:599–607.
    1. Ertel W, Morrison MH, Ayala A, Chaudry IH. Chloroquine attenuates hemorrhagic shock induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression through blockade of tumor necrosis factor and prostaglandin release. Blood. 1991;78:1781–1788.
    1. Wong GC, Clark SC. Multiple actions of interleukin 6 within a cytokine network. Immunol Today. 1988;9:137–139.
    1. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin-1 induces a shock like state in rabbits. Synergism with tumor necrosis factor and the effects of cyclooxygenase inhibition. J Clin Invest. 1988;81:1162–1172.
    1. Tracey KJ, Lowry SF, Fahey TJI, Albert JD, Fong Y, Hesse D, Beutler B, Manogue KR, Calvano S, Wei H, Cerami A, Shires GT. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet. 1987;164:415–422.
    1. Lejeune P, Lagadec P, Onier N, Pinnard D, Ohshima H, Jeannin JF. Nitric oxide involvement in tumor-induced immunosuppression. J Immunol. 1994;152:5077–5083.
    1. O'Neill PJ, Ayala A, Wang P, Ba ZF, Morrison MH, Schultze AE, Reich SS, Chaudry IH. Role of Kupffer cells in interleukin-6 release following trauma-hemorrhage and resuscitation. Shock. 1988;1:43–47.
    1. Ayala A, Meldrum DR, Perrin MM, Chaudry IH. The release of transforming growth factor-β following hemorrhage: its role as a mediator of host immunosuppression [abstract]. FASEB J. 1992;6:A1604.
    1. Miller-Graziano CL, Szabo G, Griffey K, Metha B, Kodys K, Catalano D. Role of elevated monocyte transforming growth factor beta (TGF-beta) production in posttrauma immunosuppression. J Clin Immunol. 1991;11:95–102.
    1. Waal Malefyt R, Abrams J, Bennett B, Figdor CG, Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209–1220.
    1. Faist E, Mewes A, Baker CC, Strasser T, Alkan SS, Rieber P, Heberer G. Prostaglandin E2 dependent suppression of interleukin-2 production in patients with major trauma. J Trauma. 1987;27:837–848.
    1. Knapp W, Baumgartner G. Monocyte-mediated suppression of human B lymphocyte differentiation in vitro. J Immunol. 1978;121:1177–1183.
    1. Johnston PA, Selkurt EE. Effect of hemorrhagic shock on renal release of prostaglandin E. Am J Physiol. 1976;230:831–838.
    1. Bonta IL, Parnham MJ. Immunomodulatory-antiinflammatory functions of E-type prostaglandins. Minireview with emphasis on macrophage mediated effects. Int J Immunopharmacol. 1982;4:103–109.
    1. Plaut M. The role of cyclic AMP in modulating cytotoxic T lymphocytes. I. In vivo-generated cytotoxic lymphocytes, but not in vitro-generated cytotoxic lymphocytes, are inhibited by cyclic AMP-active agents. J Immunol. 1979;123:692–701.
    1. Chaudry IH, Ayala A. Immune consequences of hypovolemic shock and resuscitation. Curr Opin Anaesthesiology. 1993;6:385–392.
    1. Ayala A, Chaudry IH. Dietary n-3 polyunsaturated fatty acid modulation of immune cell function pre- or post-trauma. Nutrition. 1995;11:1–11.
    1. Beutler B. Tumor necrosis factor and other cytokines in septic syndrome. In: Vincent JL, editor. In Sepsis. Berlin: Springer-Verlag; 1994. pp. 107–121.
    1. Shirakawa T, Tokunaga A, Onda M. Release of immunosuppressive substances after gastric resection is more prolonged than after mastectomy in humans. Int Surg. 1998;83:210–214.
    1. Feldbush TL, Hobbs MV, Severson CD, Ballas ZF, Weiler JM. Role of complement in the immune response. Fed Proc. 1984;43:2548–2552.
    1. Marks JD, Marks CB, Luce JM, Montgomery B, Turner J, Metz CA, Murray JF. Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis. 1990;141:94–97.
    1. Marano MA, Fong Y, Moldawer LL, Wei H, Calvano SE, Tracey KJ, Barie PS, Manogue K, Cerami A, Shires GT, Lowry SF. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet. 1990;170:32–38.
    1. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987;i:355–357.
    1. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989;169:333–338.
    1. Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg. 1993;80:289–297.
    1. Angele MK, Wichmann MW, Ayala A, Cioffi WG, Chaudry IH. Testosterone receptor blockade after hemorrhage in males: restoration of the depressed immune functions and improved survival following subsequent sepsis. Arch Surg. 1997;132:1207–1214.
    1. Zapata-Sirvent RL, Hansbrough JF, Cox MC, Carter WH. Immunologic alterations in a murine model of hemorrhagic shock. Crit Care Med. 1992;20:508–517.
    1. Simons RK, Hoyt DB, Winchell RJ, Rose RM, Holbrook T. Elevated selectin levels after severe trauma: a marker for sepsis and organ failure and a potential target for immounomodula-tory therapy. J Trauma. 1996;41:653–662.
    1. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA. 1992;268:3452–3455.
    1. Center for Disease Control Mortality Patterns – United States, 1989. MMWR. 1992;41:121–125.
    1. McGowan JE, Barnes MW, Finland N. Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935–1972) with special reference to hospital-acquired cases. J Infect Dis. 1975;132:316–335.
    1. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F. Gender differences in human sepsis. Arch Surg. 1998;133:1200–1205.
    1. Zellweger R, Ayala A, Stein S, DeMaso CM, Chaudry IH. Females in proestrus state tolerate sepsis better than males. Crit Care Med. 1997;25:106–110.
    1. Wichmann MW, Zellweger R, DeMaso CM, Ayala A, Chaudry IH. Enhanced immune responses in females as opposed to decreased responses in males following hemorrhagic shock. Cytokine. 1996;8:853–863. doi: 10.1006/cyto.1996.0114.
    1. Angele MK, Knoferl MW, Ayala A, Cioffi WG, Bland K, Chaudry IH. Male and female sex steroids: do they produce deleterious or beneficial effects on immune responses following trauma-hemorrhage? Surg Forum. 1998;49:43–45.
    1. Knoferl MW, Diodato MD, Angele MK, Ayala A, Cioffi WG, Bland KI, Chaudry IH. Do female sex steroids adversely or beneficially affect the depressed immune responses in males after trauma-hemorrhage? Arch Surg. 2000;135:425–433.
    1. Mannucci PM. Venous thromboembolism and hormone replacement therapy. Eur J Intern Med. 2001;12:478–483.
    1. Catania RA, Angele MK, Ayala A, Cioffi WG, Bland K, Chaudry IH. Dehydroepiandrosterone (DHEA) restores immune function following trauma-hemorrhage by a direct effect on T-lymphocytes. Cytokine. 1998;11:443–450. doi: 10.1006/cyto.1998.0458.
    1. Angele MK, Catania RA, Ayala A, Cioffi WG, Bland K, Chaudry IH. Dehydroepiandrosterone (DHEA): an inexpensive steroid hormone which decreases the mortality from sepsis. Arch Surg. 1998;133:1281–1288.
    1. Wichmann MW, Ayala A, Chaudry I. Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage. Am J Physiol. 1997;273:C1335–C1340.
    1. Angele MK, Ayala A, Monfils BA, Cioffi WG, Bland KI, Chaudry IH. Testosterone and/or low estradiol: normally required but harmful immunologically for males after trauma-hemorrhage. J Trauma. 1998;44:78–85.
    1. Angele MK, Xu YX, Ayala A, Catania RA, Cioffi WG, Bland KI, Chaudry IH. Gender differences in immune responses: increased thymocyte apoptosis occurs only in males but not in females after trauma-hemorrhage. Surg Forum. 1997;48:95–97.
    1. Gannon CJ, Napolitano LM, Pasquale M, Tracy K, McCarter RJ. Male gender increases risk of postinjury pneumonia. Surg Forum. 2001;52:468–469.
    1. Offner PJ, Moore EE, Biffl WL. Male gender is a risk factor for post-injury major infections [abstract]. In Proceedings of the 19th Meeting of the Surgical Infection Society. 1999. p. 20.
    1. Oberholzer A, Keel M, Trentz O, Ertel W. Die inzidenz von septischen komplikationen nach polytrauma ist geschlechts-spezifisch [abstract]. Hefte zu Der Unfallchirurg 63 Jahrestagung der Deutschen Gesellschaft fuer Unfallchirurgie: 1999. pp. 231–232.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere